Patent No.1: US 10, 004, 830 B2
Date of the Patent Granted: Jun. 26, 2018
Patent No.3: US 10, 149, 924 B1
Date of the Patent Granted: Dec. 11, 2018
Patent No.2: US 10, 098, 986 B1
Date of the Patent Granted: Oct. 16, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE ARTIFICIAL SKIN SUBSTITUTE AND A METHOD OF PREPARATION THEREOF
Patent No.: US 10,124,084 B2
Date of the Patent Granted: Nov. 13, 2018
Title of the Patent: READY TO USE BIODEGRADABLE AND BIOCOMPATIBLE DEVICE AND A METHOD OF PREPARATION THEREOF
Background of the Invention:
Haemostatic products are the agents which promote haemostasis (stop bleeding). These can be used for both surgical or traumatic wounds. Heavy blood loss from the wounds may result in a hypovolemic shock (when the body loses one-fifth of its blood and heart is not able to pump sufficient amount of blood to the body) leading to tissue and organ damage.
A notably large number of women are seen suffering from PCOS. Polycystic Ovarian Syndrome (PCOS) affects 1 in 10 women of childbearing age. It is a health condition which causes a woman to produce larger quantities of the male hormone, thereby tampering with the normal functioning of the woman body.
The hormonal imbalance causes the women to skip their periods and develop certain manly attributes. Things also become a little trickier when it comes to pregnancy, if untreated it can lead to infertility.
Haemophilia is a group of rare inherited blood disorders in which the blood does not clot properly. In other words, someone with hemophilia may continue to bleed for longer than normal if they are injured or start bleeding for other reasons.
Delivering Next-Gen Healing Solutions Globally
We are devoted to manufacturing & marketing of products of impeccable quality conforming to international standards.
2018 Copyrights © Datt Mediproducts Private Limited | All Rights Reserved | Powered by [i-SmokeStack] | Delivering Awareness, Inspiring Solutions
